Stonegate Updates Coverage on EnSilica PLC (AIM: ENSI) 1H 2025
DALLAS, TX -- February 18th, 2025 -- EnSilica PLC (AIM: ENSI): Stonegate Capital Partners updates their coverage on EnSilica PLC (AIM: ENSI). In 1H25, EnSilica PLC continued to build on its strategic initiatives and market strengths, achieving significant milestones. The Company's strong position and intellectual property in automotive, industrial, healthcare, and satellite connectivity applications for mixed-signal ASICs continue to provide a competitive edge. We believe that ENSI is well positioned to capitalize on the global ASIC market, which is projected to reach $25.0B by 2030. EnSilica took meaningful steps towards having a more predictable revenue stream with an increase in chip supply revenue of 164% year over year. This is expected to compound as the Company won an additional five contracts in the period. Additionally, ENSI currently has 4 ASICs in production, with another 8 in the design phase.
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- EnSilica increased chip supply revenue by 164% year over year. This is expected to compound as the Company won an additional five contracts in the period.
- ENSI currently has 4 ASICs in production, with another 8 in the design phase.
- Our valuation ranges average at £0.86 to £0.99 with a mid-point of £0.92.
Click image above to view full announcement.
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.
Contacts:
Stonegate Capital Partners
(214) 987-4121
[email protected]
Source: Stonegate, Inc.
Distributed by: Reportable, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Motorola Solutions Completes Acquisition of D-Fend Solutions
- Artelo Biosciences Secures Notice of Allowance in Japan for Patent Claims for the Intended Commercial Formulation of ART27.13
- Conduent Collaborates with Google Cloud to Expand Enterprise AI Strategy and Deliver GenAI-Powered eDiscovery Solution
Create E-mail Alert Related Categories
Press Releases, ReportableSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share